Previous slide
Next slide
Research Fields
The Main Research Areas
Welcome to Molecular Pathology Lab
Our laboratory is dedicated to comprehensively understanding the mechanisms of cancer development, identifying and validating cancer target genes, and developing innovative biomarkers and antibody-based therapy rooted in molecular biology. Our primary research areas encompass biomarker discovery, anti-cancer therapy, and biodefense.
Faculty
Shin, Young Kee
Professor
Hong, Sung Youl
Research professor
Chaithanya Chelakkot
Research professor
Guillen Quispe Yanymee Nimesia
research professor
Recent Articles
Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency
. Jiyeon Son, Hyunjung Yoo, Joonyoung Park, Hyelim Park, Seung-Eun Chong, Jungeun Lee, Jeewon Kim, Eunyoung Park, Seo-hyeon Bae, Sunhee Kang, Jaeyoung Ban, Soonhwa Song, Eunhye Oh, Heechun Kwak, Hyokyoung Kwon, Jaesung Jung, Narae Lee, Byunghoon Jung, Yuebao Zhang, Diana D. Kang, Shi Du, Young Kee Shin, Yizhou Dong, and Jae Uk Jeong
2025
Molecular Therapy Nucleic Acids
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies
Jieun Park, Chaithanya Chelakkot, Ji-Hye Nam, Hun Seok Lee, Chae Rin Kim, Yeonwoo Lee, Mi-Sook Lee, Yoon-La Choi , Young Kee Shin
2025
Target Oncol.
Reagentless aptamer based on the ultrasensitive and fast response electrochemical capacitive biosensor for EGFR detection in non-small cell lung cancer
Enkhzaya Ganbold, Nam Young Kim , Yu Mi Kim, Parshant Kumar Sharma, Do Nam Lee, Byeolnim Oh, Hyun Soo Kim, Junghan Song, Byungheon Lee, Eun-Seong Kim, Young Kee Shin, Jeong Su Park, Sang Tae Kim.
2025
Biosensors and Bioelectronics
Advancements in Passive Wireless Sensing Systems in Monitoring Harsh Environment and Healthcare Applications
Wei Yue, Yunjian Guo, Jong‐Chul Lee, Enkhzaya Ganbold, Jia-Kang Wu, Yang Li, Cong Wang, Hyun Soo Kim, Young-Kee Shin, Jun-Ge Liang, Eun-Seong Kim, Nam-Young Kim.
2025
Nano-Micro Letters
Bulletin Board
-
2025-01-31
-
2025-01-21
-
2025-01-21
-
2025-01-21